These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27300252)

  • 21. [Bruxism as a side effect of serotonin re-uptake inhibitors].
    Beers E; van Grootheest AC
    Ned Tijdschr Tandheelkd; 2007 Sep; 114(9):388-90. PubMed ID: 17937375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidental aggravation of venous malformation after botulinum toxin type a injection for reducing benign masseteric hypertrophy.
    Choi JH; Park SW; Chung HY; Choi KY; Chang HW; Kim JH; Son D; Han K; Cho HC; Xu L; Choi TH; Kim S
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2188-92. PubMed ID: 21134051
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.
    Park HU; Kim BI; Kang SM; Kim ST; Choi JH; Ahn HJ
    J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bruxism associated with serotonin reuptake inhibitors: two cases.
    Ak M; Gulsun M; Uzun O; Gumus HO
    J Clin Psychopharmacol; 2009 Dec; 29(6):620-2. PubMed ID: 19910740
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential response of pig masseter to botulinum neurotoxin serotypes a and b.
    Liu ZJ; Rafferty KL; Ye W; Herring SW
    Muscle Nerve; 2015 Jul; 52(1):88-93. PubMed ID: 26039454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression, selective serotonin reuptake inhibitors and bruxism.
    Hazara R
    Dent Update; 2015 Dec; 42(10):979. PubMed ID: 26856008
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary: The effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.
    Ahn KY
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2167. PubMed ID: 21244566
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle.
    Kim JH; Shin JH; Kim ST; Kim CY
    Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bruxism, Botox, and Dental Implants.
    Malcmacher L; Kosinski T
    Dent Today; 2017 Apr; 36(4):94, 96-7. PubMed ID: 29235317
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.
    Shim WH; Yoon SH; Park JH; Choi YC; Kim ST
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2161-6. PubMed ID: 21134047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone as an antidote to SSRI-induced bruxism in 4 cases.
    Bostwick JM; Jaffee MS
    J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
    El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
    Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.
    Song JH; Cho ES; Kim ST; Ahn HJ
    Yonsei Med J; 2014 Jul; 55(4):1123-9. PubMed ID: 24954346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular injection of botulinum toxin as an adjunct to total joint replacement in temporomandibular joint ankylosis: preliminary reports.
    Robiony M
    J Oral Maxillofac Surg; 2011 Jan; 69(1):280-4. PubMed ID: 21055863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.